Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
1993-2-25
pubmed:abstractText
OBJECTIVE--To examine if the risk for CHD increases progressively with increases in the BMI of normoglycemic, hyperinsulinemic, morbidly obese women (BMI > or = 35 kg/m2). RESEARCH DESIGN AND METHODS--Insulin sensitivity was evaluated by calculating an ISI following an OGTT. There was a significant linear relationship between ISI and BMI fitted by two straight lines intersecting at a point corresponding to a BMI of 29.7 +/- 1.5 kg/m2. Significant linear relationships between insulin sensitivity and BMI were obtained below and above this breakpoint. Similarly, a breakpoint for the relation between dBP and BMI corresponding to a BMI > or = 33.7 +/- 3.4 kg/m2 was obtained. Significant linear relationships between BMI and plasma fasting glucose, triglyceride, cholesterol, HDL cholesterol, sBP, or dBP were not observed in the women with a BMI > 35 kg/m2. RESULTS--Compared with lean (BMI < 27) women of similar age, the morbidly obese patients appear to be at a higher risk for CHD. This is suggested by statistically significant increases in fasting insulin (mean +/- SD; 187 +/- 137 vs. 64.2 +/- 16.2 pM) and triglyceride levels (128 +/- 78.1 vs. 73 +/- 25 mg/dl), sBP (132 +/- 114 vs. 104 +/- 15.8) and dBP (84 +/- 72 vs. 67 +/- 2.1 mmHg), and decreases in HDL cholesterol (1.03 +/- 0.44 vs. 1.29 +/- 0.82 mM) and apo A-I (91 +/- 55 vs. 122 +/- 35 mg/dl) concentrations. CONCLUSIONS--It appears that there may be a threshold of body mass up to which insulin sensitivity is associated with CHD risk. Above this threshold, there does not appear to be a progressive increase in the risk factors for CHD with increases in BMI.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0149-5992
pubmed:author
pubmed:issnType
Print
pubmed:volume
16
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
144-9
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:8422769-Adult, pubmed-meshheading:8422769-Apolipoprotein A-I, pubmed-meshheading:8422769-Apolipoproteins B, pubmed-meshheading:8422769-Blood Glucose, pubmed-meshheading:8422769-Blood Pressure, pubmed-meshheading:8422769-Body Mass Index, pubmed-meshheading:8422769-Body Weight, pubmed-meshheading:8422769-Cholesterol, pubmed-meshheading:8422769-Cholesterol, HDL, pubmed-meshheading:8422769-Coronary Disease, pubmed-meshheading:8422769-Female, pubmed-meshheading:8422769-Glucose Tolerance Test, pubmed-meshheading:8422769-Humans, pubmed-meshheading:8422769-Hyperinsulinism, pubmed-meshheading:8422769-Insulin, pubmed-meshheading:8422769-Obesity, Morbid, pubmed-meshheading:8422769-Reference Values, pubmed-meshheading:8422769-Regression Analysis, pubmed-meshheading:8422769-Risk Factors, pubmed-meshheading:8422769-Triglycerides
pubmed:year
1993
pubmed:articleTitle
Coronary heart disease risk factors in morbidly obese women with normal glucose tolerance.
pubmed:affiliation
Department of Biochemistry, School of Medicine, East Carolina University, Greenville, North Carolina 27858-4354.
pubmed:publicationType
Journal Article, Comparative Study